• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

COVID-19 Testing Markets, 2023

$5,000.00 – $10,000.00

Clear
SKU: 23-045 Category: Diagnostics Market Research Tags: coronavirus, COVID-19, Omicron, pandemic, vaccine Pages: 131
  • Description
  • Table of Contents
  • Latest reports

Description

Covid-19 testing has been at the forefront in battling the pandemic. However, as the pandemic recedes and becomes more endemic, what will happen to the ever-changing COVID-19 testing market? Kalorama Information answers this question and more in COVID-19 Testing Markets, 2023.

The pandemic has been a learning curve for all parties to invest in diagnostic systems, as COVID-19 aptly pointed out. Notably, the pandemic reinforced the importance of testing and a significant number of companies are increasing their development of a wide selection of diagnostic tests in all markets. Diagnostics have been critical in the response to COVID-19.

This report provides market sizing and estimates for COVID-19 tests with discussion of market impacts of COVID-19.

Some of the key topics and trends explored include:

  • At-Home Testing
  • Insurance Coverage
  • Multiplex Testing
  • Expiration of Public Health Emergency
  • New Variants on the Horizon
  • Immunoassay Testing
  • Molecular Testing

Global Regional Analysis

The report’s global analysis features research, such as 2022-2027 sales estimates and forecasts, for regions and countries including:

  • APAC
  • Europe
  • North America
  • Rest of World
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • China
  • Denmark
  • France
  • Germany
  • India
  • Italy
  • Mexico
  • Netherlands
  • Japan
  • Poland
  • Romania
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
  • United States

Competitive Analysis

The report includes analysis and profiles of key companies competing in this industry, including a breakout of the top competitors in the COVID-19 testing market based on 2022 manufacturer revenues.

Companies profiled include:

  • Abbott
  • Access Bio, Inc
  • Becton-Dickinson
  • BioMérieux
  • Bio-Rad
  • Cue Health
  • Danaher corporation
  • Diasorin
  • ELITechGroup
  • Genedrive plc
  • Hologic
  • LumiraDx UK
  • OraSure Technologies
  • PerkinElmer, Inc
  • Qiagen
  • QuantuMDx
  • QuidelOrtho
  • Roche Diagnostic Corporation
  • Seegene
  • Siemens Healthineers
  • Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co)
  • Thermo Fisher Scientific

Scope and Methodology

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews, in-person interviews and email correspondence were the primary methods of gathering information. For the purpose of this study, Kalorama Information conducted interviews with industry officials, consultants, health care providers, and government personnel.  These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report.  Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers’ level. The market includes manufacturer tests.  The base year for data was 2022. Data are provided for 2022 and 2027 with compound annual growth rates (CAGRs) for 2022 and 2027. Competitive analysis is provided for the top ten participants in the market. Regional breakdowns are surveyed for North America, Europe, Asia-Pacific and Rest of World. The forecasted market analysis through 2027 was largely based on demographic trends, new developments, trajectory of COVID-19 and its variants, innovative technology and global use.

Table of Contents

Chapter 1: Executive Summary

Industry at a Glance

Scope and Methodology

Size and Growth of the Market

  • Table 1-1: Global COVID-19 Testing (Immunoassay, Molecular, Rapid) Sales by Segment, 2022-2027
  • Figure 1-1: Global COVID-19 Market by Key Segment (Molecular, Immunoassay), 2020-2027

Key Issues and Trends Affecting the Market

Competitive Outlook

Conclusion Highlights

 

Chapter 2: Introduction

Overview

  • Figure 2-1: Coronavirus (COVID-19) 7-Day Case Snapshot Global by Country
  • Table 2-1: Coronavirus (COVID-19) Situation by WHO Region (Africa, Americas, Eastern Mediterranean,  Europe, South-East Asia, West Pacific)
  • Figure 2-2: Coronavirus (COVID-19) Cumulative Cases and 7-Day Cases by WHO Region (Africa, Americas, Eastern Mediterranean,  Europe, South-East Asia, West Pacific)
  • Figure 2-3: Country-Level COVID-19 Cumulative Cases, by Country (Australia, Brazil, Canada, France, Germany, India, Indonesia, Italy, Japan, Mexico, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, United Kingdom, United States, Vietnam), Through April 11, 2023
  • Figure 2-4: Country-Level COVID-19 Cumulative Diagnostic Tests Administered, by Country (Australia, Brazil, Canada, France, Germany, India, Indonesia, Italy, Japan, Mexico, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, United Kingdom, United States, Vietnam), Through April 11, 2023
  • Figure 2-5: New Cases vs. Total Cases for Select Countries with Uptick in Cases, by Country (Afghanistan, Austria, Czechia, Hong Kong, Indonesia, Japan, Mexico, Pakistan, Philippines, Poland, Russia, Saudi Arabia, South Korea, Vietnam), April 2023

 

Chapter 3: Issues and Trends

At-Home Testing

  • Figure 3-1: At-Home COVID-19 Test Distribution of Sales, by Vendor (Abbott Diagnostics, Becton Dickinson, OraSure Technologies, Quidel, Siemens Healthineers, Others)

Insurance Coverage

Multiplex Testing

EUAs and Public Health Emergency Expiration

New Variants On the Horizon

 

Chapter 4: COVID-19 Immunoassay Testing

Overview

Enzyme-linked Immunosorbent Assay (ELISA)

Mass Spectrometry

Rapid

Products

Antigen

  • Table 4-1: Selected Antigen Immunoassay Tests for SARS-CoV-2

Antibody

  • Table 4-2: Selected Antibody Immunoassay EUA Tests for COVID-19

Market Size and Growth

  • Table 4-3: Global Immunoassay COVID-19 Testing Market, 2022-2027 $MN; CAGR 2022-2027
  • Table 4-4: Estimated Global Immunoassay COVID-19 Testing Market Distribution by Segment (Antigen, Serology) and End User (Laboratory, Rapid/Near Patient), 2022, (%)

Competitive Market Share

  • Figure 4-1: Immunoassay COVID-19 Vendor Market Share, by Vendor (Abbott, Beckman Coulter-Danaher, Becton Dickson, Diasorin, Fujirebio Diagnostics, PerkinElmer, QuidelOrtho, Roche, Siemens, ThermoFisher, Others), 2022 (%)

 

Chapter 5: COVID-19 Molecular Testing

Overview

Products

  • Table 5-1: Selected Molecular EUA Tests for COVID-19

Market Size and Growth

  • Table 5-2: Estimated Global Molecular COVID-19 Testing Market, 2022-2027 $MN; CAGR 2022-2027
  • Table 5-3: Estimated Global Molecular COVID-19 Testing Market Distribution by End User (Laboratory, Rapid/Near Patient), 2022 (%)

Competitive Market Share

  • Figure 5-1: Molecular COVID-19 Vendor Market Share, by Vendor (Abbott, bioMérieux, Cepheid-Danaher, Hologic, Orasure Technologies, PerkinElmer, Qiagen, QuidelOrtho, Roche, ThermoFisher, Others), 2022 (%)

 

Chapter 6: Total COVID-19 Testing Market Summary

Market Overview

  • Table 6-1: Global COVID-19 Testing (Immunoassay, Molecular, Rapid) Sales, by Segment, 2022-2027 ($MN)
  • Figure 6-1: Global IVD Market (COVID-19 Assays and Instruments, Excluding COVID-19 Assays and Instruments), 2019-2022, ($MN)
  • Figure 6-2: Global IVD Market, Distribution by Performance Segment (COVID-19 Assays and Instruments, Excluding COVID-19 Assays and Instruments), 2022 (%)

Market Segment by Test Type/Site

  • Table 6-2: Global COVID-19 Testing by Test Site (Laboratory, Rapid/Near Patient) Sales by Segment, 2022-2027
  • Figure 6-3: Global COVID-19 IVD Market by Test Site, 2020-2022 and Forecast Through 2027 ($MN)

Laboratory Based

  • Table 6-3: Global Lab-based COVID-19 Testing Market, Distribution of Sales by Segment (Immunoassay, Molecular), 2022-2027 ($MN)

Point of Care

  • Table 6-4: Global Rapid-based COVID-19 Testing Market, Distribution of Sales by Segment (Immunoassay, Molecular), 2022-2027 ($MN)
  • Figure 6-4: Global COVID-19 IVD Market by Test Method, 2020-2022 and Forecast Through 2027 ($MN)

Market by Region

  • Figure 6-5: Estimated Global COVID-19 Testing Market by Region (APAC, Europe, North America, Rest of World), 2020-2022
  • Figure 6-6: COVID-19 Testing Market by Country (Australia, Austria, Belgium, Brazil, Canada, China, Denmark, France, Germany, India, Italy, Mexico, Netherlands, Japan, Poland, Romania, South Africa, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States), Estimated 2022 ($M)

Competitive Analysis

  • Figure 6-7: Top 10 COVID-19 Vendors and Global Market Share, by Vendor (Abbott, bioMérieux, Danaher, Hologic, PerkinElmer, Qiagen, QuidelOrtho, Roche, Siemens, ThermoFisher, Others), 2022

 

Chapter 7: Selected Market Participants

Abbott

  • Table 7-1:  Abbott Corporate Summary

Company Overview

COVID-19

Access Bio, Inc

  • Table 7-2:  Access Bio Corporate Summary

Company Overview

COVID-19

Becton-Dickinson

  • Table 7-3:  Becton-Dickinson Corporate Summary

Company Overview

COVID-19

bioMérieux

  • Table 7-4:  bioMérieux Corporate Summary

Company Overview

COVID-19

Bio-Rad

  • Table 7-5:  Corporate Summary

Company Overview

COVID-19

Cue Health

  • Table 7-6:  Cue Health Corporate Summary

Company Overview

COVID-19

Danaher Corporation

  • Table 7-7:  Danaher Corporate Summary

Company Overview

COVID-19

DiaSorin S.p.A.

  • Table 7-8:  DiaSorin Corporate Summary

Company Overview

COVID-19

ELITech Group S.A.S.

  • Table 7-9:  ELITech Group Corporate Summary

Company Overview

COVID-19

Genedrive plc

  • Table 7-10:  Genedrive Corporate Summary

Company Overview

COVID-19

Hologic, Inc

  • Table 7-11:  Hologic Corporate Summary

Company Overview

COVID-19

LumiraDx UK Limited

  • Table 7-12:  LumiraDx Corporate Summary

Company Overview

COVID-19

OraSure Technologies, Inc.

  • Table 7-13:  OraSure Technologies Summary

Company Overview

COVID-19

PerkinElmer, Inc

  • Table 7-14:  PerkinElmer Corporate Summary

Company Overview

COVID-19

QIAGEN N.V.

  • Table 7-15: QIAGEN Corporate Summary

Company Overview

COVID-19

QuantuMDx Group, Ltd.

  • Table 7-16:  QuantuMDx Corporate Summary

Company Overview

COVID-19

QuidelOrtho Corporation

  • Table 7-17:  QuidelOrtho Corporate Summary

Company Overview

COVID-19

Roche Diagnostic Corporation

  • Table 7-18:  Roche Diagnostic Corporate Summary

Company Overview

COVID-19

Seegene, Inc

  • Table 7-19:  Seegene Corporate Summary

Company Overview

COVID-19

Siemens Healthineers GmbH

  • Table 7-20: Siemens Healthineers Corporate Summary

Company Overview

COVID-19

Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co)

  • Table 7-21:  Snibe Corporate Summary

Company Overview

COVID-19

ThermoFisher Scientific

  • Table 7-22:  Thermo Fisher Scientific Corporate Summary

Company Overview

COVID-19

    Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
    June 12, 2025
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025

Related products

  • Placeholder image

    U.S. Market for Molecular Diagnostics, 2nd Edition

    $3,500.00 – $7,000.00
  • Placeholder image

    The Worldwide Market for In Vitro Diagnostic Tests, 5th Edition

    $3,900.00 – $7,800.00
  • Placeholder image

    Cell-Based Diagnostics: Technology, Applications, and Markets

    $3,500.00 – $7,000.00
  • Placeholder image

    Genetic Testing: Markets and Users in Medical, Forensic, Paternity, and Food Safety Applications

    $2,625.00 – $5,250.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 10th Edition Clinical Laboratory Services Market, 8th Edition
Scroll to top